![](/img/cover-not-exists.png)
PCV20 COST EFFECTIVENESS OF ANTIHYPERTENSIVE MONO-THERAPYWITH PERINDOPRIL OR ENALAPRIL IN ELDERLY PATIENTS FROM THE THIRD PARTY PAYER PERSPECTIVE
T Hermanowski, R Jaworski, M Czech, R PachockiVolume:
7
Year:
2004
Language:
english
DOI:
10.1016/s1098-3015(10)65802-0
File:
PDF, 64 KB
english, 2004